CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist
  • 16.61
  • +0.04+0.24%
Not Open Nov 6 15:00 CST
18.92BMarket Cap22.24P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DaShenLin Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.36B
6.39B
+21.55M
Beat Est.
+11.04%
+11.42%
+0.34%
Net Income
--
212.96M
--
-20.72%
Analyst Rating
Strong Buy

Nov 6, 2024

DaShenLin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.159B--
--2024/Q4-- / 7.282B--
Oct 31, 20242024/Q36.386B / 6.364B--
Aug 31, 20242024/Q26.593B / 7.259B--
--2024/Q16.752B / 6.842B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.159B--
--2024/Q4-- / 7.282B--
Oct 31, 20242024/Q36.386B / 6.364B--
Aug 31, 20242024/Q26.593B / 7.259B--
--2024/Q16.752B / 6.842B--

Unlock Free Earnings Estimates

DaShenLin Pharmaceutical Group Earnings Reports

  • Dashanlin: Dashanlin Pharmaceutical Group Co., Ltd. Third Quarter Report 2024

    Oct 30 12:00 ET

  • Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the main operating data for the third quarter of 2024

    Oct 30 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024

    Oct 30 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report

    Aug 30 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Strong Buy

      77.27%

    • Buy

      22.73%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data